Published in Volume
119, Issue 2 (February 2, 2009)
J Clin Invest. 2009;119(2):421–421.
doi:10.1172/JCI36479C1.
Copyright © 2009, American Society for Clinical
Investigation
Corrigendum
Endocrine functions of bone in mineral metabolism
regulation
L. Darryl Quarles
Published February 2, 2009
Original citation: J. Clin. Invest.
118:3820-3828 (2008). doi:10.1172/JCI36479.
Citation for this corrigendum: J. Clin. Invest.
119:421 (2009). doi:10.1172/JCI36479C1.
The author wishes to clarify that heterozygous mutations in the SCL34A1
gene have been described in only 2 individuals with nephrolithiasis, renal phosphate
loss, and hypophosphatemia (Prié, D., et al. 2002. Nephrolithiasis and
osteoporosis associated with hypophosphatemia caused by mutations in the type 2a
sodium-phosphate cotransporter. N. Engl. J. Med.
347:983–991).
After acceptance of this JCI Science in Medicine article for publication, 3 distinct
mutations in NHERF1 were reported in 7 patients with renal phosphate
loss and nephrolithiasis and/or bone demineralization (Karim, Z., et al. 2008.
NHERF1 mutations and responsiveness of renal parathyroid hormone.
N. Engl. J. Med.
359:1128–1135).
